Huai Jiao

Sophora japonica L. (syn. Styphnolobium japonicum (L.) Schott)

Also known as: Pagodatree Pod(English) 槐角(Chinese)

Goegak槐角 괴각 Huai Chiao

Updated October 23, 2026 · Not yet clinically reviewed

Huai Jiao
Curtis's Botanical Magazine, 1918 · public domain, via Wikimedia Commons

Safety at a glance

Note

3 recorded drug interactions

Note

Contraindications or side effects are listed

No rule in our tables for this herb: pregnancy, breastfeeding, incompatible pairs (十八反 / 十九畏), herb–drug, dose ceiling. This is not a safety clearance.
Not graded —

No toxicity grade is recorded. Most herbs in the catalogue carry none.

Traditional Chinese Medicine

Category
regulating blood
Temperature
Cold
Taste
Bitter
Channels
Liver,Large Intestine

Functions

Clears Heat and Drains Fire; Cools the Blood and Stops Bleeding; Clears Liver Heat; Moistens the Intestines and Unblocks the Bowels

Traditional uses

Huai Jiao (sophora fruit, pagoda tree fruit) is a cold, bitter herb with a primary affinity for the Large Intestine channel, where it cools Blood Heat and stops bleeding. It is used for hemorrhoidal bleeding, rectal bleeding from Damp-Heat, and other Large Intestine bleeding conditions from blood Heat. It also clears Liver Fire for red, painful eyes, headache, and dizziness. As the fruit of the same tree that yields Huai Hua Mi (sophora flower bud), it shares similar channel affinities but has a stronger, more astringent action.

Western herbalism

Properties: astringent, antioxidant

Pharmacological effects

  • Hyperglycemic: An extract transiently raised blood glucose and glycosuria in rabbits 1 h after dosing; recovered within a day.
  • Antibacterial: Inhibitory against staphylococcus and E. coli.

Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 415.

Formulas using this herb

2 of 2 formulas

Botanical

Styphnolobium japonicum (syn. Sophora japonica), the Japanese pagoda tree or Huai, is a deciduous tree in the Fabaceae family, native to China and Korea and widely planted as a street and ornamental tree across temperate regions. It reaches 10-25 m with a broad rounded crown and dark gray, fissured bark. Pinnately compound leaves bear 7-17 ovate-lanceolate leaflets 2-6 cm long, with a pale glaucous undersurface. Creamy yellow-white pea-shaped flowers are borne in large terminal panicles 15-30 cm long in mid to late summer. Huai Jiao is the dried mature legume pod, indehiscent, constricted between seeds like beads.

Family
Fabaceae
Pharmaceutical name
Fructus Sophorae
Parts used
fruit
Plant type
tree

Constituents

Sophoricoside

Isoflavone glycoside (genistein 4'-O-beta-D-glucoside) · a principal isoflavone of the ripe fruit; no reliable percentage of the crude drug is established in the sources consulted

The characteristic isoflavone of the fruit rather than of the flower. It was isolated from fresh fruits by activity-guided fractionation as the most potent interleukin-5 inhibitor of the drug, with an IC50 of 1.5 micromolar in the mIL-5-dependent Y16 proliferation assay, about twenty times more potent than the oxyphenbutazone control. It is the glucoside of genistein and is deglycosylated to that aglycone before most of its systemic activity is expressed.

Sophorabioside

Isoflavone glycoside (genistein 4'-O-rutinoside)

Described as abundant in the fruits and small branches, where it is more plentiful than sophoricoside itself. Removal of its terminal rhamnose by an alpha-L-rhamnosidase converts it to sophoricoside, which is the more bioavailable and more active form; this is the basis of enzymatic upgrading processes for fruit extracts.

Genistein

Isoflavone aglycone

The aglycone released from sophoricoside and sophorabioside, and a well-characterised phytoestrogen. Together with sophoricoside it is absent from genuine Ginkgo biloba leaf, which is why the pair serve as the analytical markers for detecting sophora fruit in adulterated ginkgo extracts.

Genistin

Isoflavone glycoside (genistein 7-O-glucoside)

Isolated from the seed. In MCF-7 cells it produced a significant estrogenic proliferative effect at sub-cytotoxic concentrations, with minimal membrane damage on LDH leakage assay, which is the main reason to treat this drug as hormonally active.

Sophoraflavonoloside

Flavonol glycoside (kaempferol 3-O-sophoroside)

One of seven metabolites isolated from Sophora japonica seed alongside genistin, sophoricoside, sophorabioside and rutin. It is a flavonol rather than an isoflavone and contributes to the total flavonol glycoside content of the drug.

Rutin

Flavonol glycoside (quercetin 3-O-rutinoside)

Present in the fruit, although the flower bud is the commercially exploited source of this compound. The fruit's flavone and flavonol glycoside content is precisely what makes it attractive as a cheap adulterant of standardised Ginkgo biloba extracts, which are specified on flavonol glycoside content.

Quercetin

Flavonol

Reported among the major active constituents of the species. It is an antioxidant and a weak phytoestrogen, and is one of the flavonoids for which potential drug interactions have been flagged in regulatory safety reviews of this plant.

Kaempferol

Flavonol

Reported among the major active constituents of the species, largely present as glycosides in the fruit. Contributes to the antioxidant and anti-inflammatory profile attributed to the drug.

Isorhamnetin

Flavonol (3'-O-methylquercetin)

Listed among the major active constituents of Sophora japonica. It is a methylated quercetin derivative and part of the flavonol fraction of the fruit.

Drug interactions

Ginkgo biloba leaf extract (adulteration of the ginkgo product with this herb)

Moderate · A patient taking a ginkgo product may actually be receiving sophora fruit isoflavones, so the expected ginkgo effect is not delivered and an unlabelled phytoestrogen is · Evidence level: Established

Ginkgo biloba leaf extract is one of the most heavily traded herbal extracts and there have been repeated reports of adulteration of the leaf material or the extract with Styphnolobium japonicum fruit, which is rich in flavone glycosides and therefore cheaply satisfies the flavonol glycoside content specification. Bampali and colleagues analysed 33 authenticated ginkgo leaf samples from controlled plantations in China, the USA and France and confirmed that genuine ginkgo leaf contains neither genistein nor sophoricoside; both are therefore valid markers, and HPLC-UV/HRMS reliably detected adulteration at 2 percent or more of sophora fruit in the investigated ginkgo extract. This is the direction of substitution that matters commercially: sophora fruit goes into ginkgo, not the reverse.

Clinical note: If a patient reports taking ginkgo alongside or instead of this herb, the two may not be chemically distinct in the bottle. Prefer ginkgo products whose certificate of analysis reports genistein and sophoricoside as absent, and treat an unexplained isoflavone exposure as possible when a patient on ginkgo shows hormone-sensitive effects.

Tamoxifen, aromatase inhibitors and other endocrine therapy for hormone-sensitive cancer

Theoretical · Possible opposition to the intended anti-estrogenic effect of the drug · Evidence level: Possible

The fruit and seed carry a substantial isoflavone load, and genistin, sophoricoside and genistein 7,4'-di-O-beta-D-glucopyranoside all produced significant estrogenic proliferative effects in MCF-7 breast cancer cells at sub-cytotoxic concentrations. Sophoricoside also showed anti-osteoporotic activity in ovariectomised rats after oral dosing at 15 and 30 mg/kg, which is consistent with systemic estrogen-receptor-mediated activity after oral administration. No human pharmacodynamic or clinical interaction study exists, so the direction and magnitude in a patient on endocrine therapy are unknown.

Clinical note: Avoid prescribing this drug long term to patients on tamoxifen or an aromatase inhibitor, and to patients with an estrogen-receptor-positive tumour, until human data exist. Short courses for acute bleeding are a different risk proposition from months of daily use.

Broad-spectrum antibiotics (effect on the herb, not on the antibiotic)

Theoretical · Possible loss of the herb's activity rather than any harm · Evidence level: Theoretical

The dominant fruit constituents sophorabioside and sophoricoside are glycosides, and the aglycone genistein is the more bioavailable and more pharmacologically potent form. Deglycosylation is the activating step, and for isoflavone glycosides generally that step is carried out by intestinal microbial glycosidases. Antibiotic suppression of the gut flora would therefore be expected to reduce conversion. This has not been measured for Fructus Sophorae specifically and no clinical consequence has been reported.

Clinical note: No action is needed for safety. If the herb appears ineffective in a patient who has recently completed a course of broad-spectrum antibiotics, incomplete activation of the isoflavone glycosides is a plausible explanation rather than a wrong pattern diagnosis.

Dosage

FormAmountFrequencyNotes
decoction6–9 gDaily
中国药典 2020 【用法与用量】6~9g。 【性味与归经】苦,寒。归肝、大肠经。 — Chinese Pharmacopoeia 2020, quoted verbatim; route and cautions preserved. Replaces a cleared category-filler value.

Dui yao: classical pairings

Huai Jiao + Di Yu地榆

Together they clear Large Intestine heat and cool the blood to stop bleeding from the lower bowel.

Hemorrhoidal bleeding and bloody stools from intestinal wind and damp-heat.

Core pair of a classical formula — Huai Jiao Wan, Tai Ping Hui Min He Ji Ju Fang

Evidence

Study design on record, not certainty of outcome.

In vitro / animal
4

Sophoricoside Analogs as the IL-5 Inhibitors from Sophora japonica

Min B, Oh SR, Lee HK, Takatsu K, Chang IM, Min KR, Kim Y · Planta Medica · 1999 · in vitro

In vitro / animal · Verified

Activity-guided fractionation of fresh fruits of Sophora japonica yielded sophoricoside, genistein, orobol and genistin as inhibitors of interleukin-5 in the mIL-5-dependent Y16 proliferation bioassay. Sophoricoside was the most potent, with 89 percent inhibition at 12.5 micromolar and an IC50 of 1.5 micromolar, against 31.7 micromolar for the oxyphenbutazone positive control. This is fruit material specifically, not the flower or bud.

doi:10.1055/s-1999-14016

Isolation of Antiosteoporotic Compounds from Seeds of Sophora japonica

Abdallah HM, Al-Abd AM, Asaad GF, Abdel-Naim AB, El-halawany AM · PLoS ONE · 2014 · animal

In vitro / animal · Not yet verified

Seven metabolites were isolated from Sophora japonica seeds: genistin, sophoricoside, sophorabioside, sophoraflavonoloside, genistein 7,4'-di-O-beta-D-glucopyranoside, a kaempferol triglycoside and rutin. Genistin, sophoricoside and the genistein diglucoside showed significant estrogenic proliferative effects in MCF-7 cells at sub-cytotoxic concentrations with minimal LDH leakage. Sophoricoside was then tested orally at 15 and 30 mg/kg in ovariectomised rats and showed anti-osteoporotic activity. The estrogenic cell data are the most clinically relevant finding here.

doi:10.1371/journal.pone.0098559

Sophoricoside, a genistein glycoside from Fructus Sophorae, promotes hair growth via activation of M4 muscarinic AChR in dermal papilla cells

Yuen GKW, Lin S, Dong TTX, Tsim KWK · Journal of Ethnopharmacology · 2024 · in vitro

In vitro / animal · Not yet verified

Fructus Sophorae extract and its marker isoflavone sophoricoside promoted hair growth signalling in cultured dermal papilla cells, an effect the authors attribute to allosteric activation of the M4 muscarinic acetylcholine receptor supported by molecular docking. The work is cell-based and preclinical and supports no clinical claim, but it is one of the few pharmacological studies performed on the fruit rather than on the flower or bud.

doi:10.1016/j.jep.2024.118585

HPLC-UV/HRMS methods for the unambiguous detection of adulterations of Ginkgo biloba leaves with Sophora japonica fruits on an extract level

Bampali E, Germer S, Bauer R, Kulić Ž · Pharmaceutical Biology · 2021 · in vitro

In vitro / animal · Not yet verified

Thirty-three authenticated Ginkgo biloba leaf samples from controlled plantations in China, the USA and France were analysed by two HPLC-UV/HRMS methods. Genuine ginkgo leaf contained neither genistein nor sophoricoside, establishing both as valid markers for sophora fruit adulteration. The methods reliably detected adulteration at 2 percent or more of sophora fruits in the investigated ginkgo extract.

doi:10.1080/13880209.2021.1910717

Safety

Contraindications

Its use is prohibited in pregnant women and patients with deficiency-cold of the spleen and stomach.

Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, p. 211.

Cultural and historical

Shen Nong Ben Cao Jing · Han dynasty

Records Huai Shi, the fruit of the huai tree, as the medicinal part. The fruit, not the flower, is the anciently recorded drug of this species; Huai Hua, the flower, enters the materia medica considerably later.

Ben Cao Gang Mu · Ming dynasty

Li Shizhen treats the flower, the unopened flower bud, the fruit, the branch, the bark and the root of the huai tree as separate entries with different indications, which is the classical basis for dispensing Huai Hua, Huai Mi and Huai Jiao as distinct drugs rather than as one herb.

References

  1. He X, Bai Y, Zhao Z, Wang X, Fang J, Huang L, Zeng M, Zhang Q, Zhang Y, Zheng X. Local and traditional uses, phytochemistry, and pharmacology of Sophora japonica L.: A review. Journal of Ethnopharmacology. 2016 doi:10.1016/j.jep.2016.04.014
  2. Guo N, Chen Z, Cao SQ, Shang FD. Sophora japonica L. bioactives: Chemistry, sources, and processing techniques. Food Frontiers. 2024 doi:10.1002/fft2.367
  3. Madden E, McLachlan C, Oketch-Rabah H, Calderón AI. United States Pharmacopeia comprehensive safety review of Styphnolobium japonicum flower and flower bud. Phytotherapy Research. 2022 doi:10.1002/ptr.7438
  4. Kang SH, Kim YS, Lee H, Shin KC. Biotransformation of Sophorabioside in the Fruits and Small Branches of Sophora japonica into Sophoricoside Using α-L-Rhamnosidase from Chloroflexus aurantiacus. Journal of Microbiology and Biotechnology. 2025 doi:10.4014/jmb.2505.05034

Look-alike names

© Verscienta Health — use subject to the API terms at https://verscienta.com/developers/api; educational reference, not medical advice